M. Oshima et al., SUPPRESSION OF INTESTINAL POLYPOSIS IN APC(DELTA-716) KNOCKOUT MICE BY INHIBITION OF CYCLOOXYGENASE 2 (COX-2), Cell, 87(5), 1996, pp. 803-809
Two cyclooxygenase isozymes catalyze conversion of arachidonic acid to
prostaglandin H-2: constitutive COX-1 and inducible COX-2. To assess
the role of COX-2 in colorectal tumorigenisis, we determined the effec
ts of COX-2 gene (Ptgs2) knockouts and a novel COX-2 inhibitor on Apc(
Delta 716) knockout mice, a model of human familial adenomatous polypo
sis. A Ptgs2 null mutation reduced the number and size of the intestin
al polyps dramatically. Furthermore, treating Apc(Delta 716) mice with
a novel COX-2 inhibitor reduced the polyp number more significantly t
han with sulindac, which inhibits both isoenzymes. These results provi
de direct genetic evidence that COX-2 plays a key role in tumorigenesi
s and indicate that COX-2-selective inhibitors can be a novel class of
therapeutic agents for colorectal polyposis and cancer.